Skip to main content
Image of syringe and pipets)

Therapeutic Areas and Products


Key Publications

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomized, double-blind, placebo-controlled trial
Chapman KR, et al. Lancet. 2015
Request | Ask a Question

Multi-Center Study: The Biochemical Efficacy, Safety and Tolerability of a New α1-Proteinase Inhibitor, Zemaira
Stocks J, et al. COPD. 2006
Request | Ask a Question

For U.S. Healthcare Professionals only
For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US Healthcare Professional